Valor20202021202220232024TTMGastos comerciales, generales y administrativos8.85 B10.54 B7.78 B8.66 B8.51 B8.28 BInvestigación y desarrollo——————Beneficio operativo-5.04 B2.04 B4.38 B3.91 B4.42 B5.65 BTotal de ingresos no operativos223 M259 M497 M132 M202 M169 MGastos por intereses, netos de intereses capitalizados217 M178 M248 M252 M265 M231 MIngresos no operativos, una vez deducidos los gastos por intereses-24 M-22 M-30 M-154 M-25 M209 MIngresos/gastos extraordinarios30 M103 M279 M34 M-38 M—Beneficio antes de impuestos-5.03 B1.93 B4.63 B3.79 B4.36 B5.59 BParticipación en los beneficios48 M43 M5 M4 M9 M—Impuestos-695 M636 M905 M629 M878 M1.04 BParticipación minoritaria199 M173 M162 M158 M186 M210 MOtros ingresos/gastos después de impuestos-188 M-501 M-298 M-233 M-424 M-422 MBeneficio neto antes de actividades interrumpidas-4.54 B1.12 B3.56 B3 B3.29 B4.34 BOperaciones suspendidas-1 M-5 M-3 M00—Beneficio neto-4.54 B1.11 B3.56 B3 B3.29 B4.34 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas-4.54 B1.11 B3.56 B3 B3.29 B4.34 BBeneficio básico por acción-28.267.3225.2322.5425.8634.82Beneficio por acción diluido-28.267.2325.0322.3925.7234.66Número medio de acciones ordinarias160.6 M152.3 M141.1 M133.2 M127.4 M499.5 MAcciones diluidas160.6 M154.1 M142.2 M134.1 M128.1 M501.7 MEBITDA-4.7 B2.35 B4.65 B4.19 B4.69 B6.34 BEBIT-5.04 B2.04 B4.38 B3.91 B4.42 B5.65 BCosto de los ingresos226.08 B250.84 B264.35 B296.12 B345.73 B383.81 BOtros costes de producción——————Amortización y depreciación (flujo de caja)344 M312 M272 M279 M272 M684 M
McKesson Corporation
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.